
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:creator>Radojičić, Ognjen</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-2042-0056">Nedić, Olgica</dc:creator>
  <dc:creator>Miković, Željko</dc:creator>
  <dc:creator>Mandić Marković, Vesna</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-8691-2486">Gligorijević, Nikola</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-6423-4645">Robajac, Dragana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-4652-7719">Dobrijević, Zorana</dc:creator>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:publisher>Springer</dc:publisher>
  <dc:subject xml:lang="srp">gestational diabetes, miR-27a, miR-222, miR-340, PBMC</dc:subject>
  <dc:description xml:lang="eng">ABSTRACT
Background: Dysregulation of microRNA-based mechanisms is associated with various human pathologies, including gestational diabetes mellitus (GDM), suggesting they may be potential diagnostic and/or prognostic biomarkers of GDM. 
Methods: The expression of miR-340-5p, miR-27a-3p and miR
222-3p in peripheral blood mononuclear cells (PBMCs) obtained from patients with GDM (n = 42) and healthy controls (n = 34) were evaluated, together with their correlation to the clinical parameters of participants and their newborns. Expression of the selected microRNAs was quantified by quantitative real-time polymerase chain reaction (qPCR), after reverse transcription with microRNA-specific stem-loop primers. 
Results: The expression of miR-27a-3p was significantly higher in patients with GDM than in controls (p = 0.036), whereas no significant difference between groups was found for the other two tested microRNAs. The expression level of miR-27a-3p in GDM patients was found to negatively correlate with the number of erythrocytes, concentration of haemoglobin, haematocrit, and low- and high-density lipoprotein (LDL/HDL) ratio, and positively with the concentration of glycated haemoglobin (HbA1c). In the case of miR-222-3p, a negative correlation between its expression and the concentration of cholesterol, LDL and LDL/HDL ratio was found only in healthy pregnant women. The expression level of miR-340-5p negatively correlated with erythrocyte count, haemoglobin concentration and haematocrit in GDM patients, as well as with the concentration of cholesterol, LDL and LDL/HDL ratio in healthy women. 
Conclusions: The results obtained illustrate the potential of PBMC-derived microRNA miR-27a-3p to serve as a diagnostic biomarker of GDM. On the other hand, MiR-27a and miR-340 may help in assessing the metabolic status relevant for pregnancy. </dc:description>
  <dc:description xml:lang="eng">&quot;Accepted version&quot;</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:format>935581 bytes</dc:format>
  <dc:title xml:lang="eng">Gestational diabetes is associated with an increased expression of miR-27a in peripheral blood mononuclear cells</dc:title>
  <dc:source>Molecular Diagnosis &amp; Therapy</dc:source>
  <dc:source>vol. 26</dc:source>
  <dc:source>br. 4</dc:source>
  <dc:source>str. 421-435</dc:source>
  <dc:rights>All rights reserved</dc:rights>
  <dc:date>2022</dc:date>
  <dc:language>eng</dc:language>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:34488</dc:identifier>
  <dc:identifier>doi:10.1007/s40291-022-00591-5 </dc:identifier>
</oai_dc:dc>
